RXII - RXi Pharmaceuticals Corporation

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts0011
Avg. Estimate00-1.14-0.33
Low Estimate00-1.14-0.33
High Estimate00-1.14-0.33
Year Ago EPS-1.2-1.1N/A-1.14
Revenue EstimateCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
No. of Analysts1011
Avg. Estimate50kN/A180k240k
Low Estimate50kN/A180k240k
High Estimate50kN/A180k240k
Year Ago SalesN/AN/AN/A180k
Sales Growth (year/est)N/AN/AN/A33.30%
Earnings History3/30/20176/29/20176/29/20189/29/2018
EPS Est.-1.1-1.1-0.62-0.38
EPS Actual-1.2-1.1-0.46-0.34
Difference-0.100.160.04
Surprise %-9.10%0.00%25.80%10.50%
EPS TrendCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Current Estimate00-1.14-0.33
7 Days Ago-0.11-0.08-1.14-0.33
30 Days Ago-0.11-0.08-1.14-0.33
60 Days Ago-0.35-0.37-1.88-1.23
90 Days Ago-0.35-0.37-1.88-1.23
EPS RevisionsCurrent Qtr. (Dec 2018)Next Qtr. (Mar 2019)Current Year (2018)Next Year (2019)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days11N/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRXIIIndustrySectorS&P 500
Current Qtr.N/AN/AN/A0.48
Next Qtr.N/AN/AN/A0.40
Current YearN/AN/AN/A0.21
Next Year71.10%N/AN/A0.10
Next 5 Years (per annum)N/AN/AN/A0.11
Past 5 Years (per annum)N/AN/AN/AN/A